Genprex, Inc. Common Stock GNPX
Key Stats
- Today's Range
- $4.65 – $5.46
- 50-Day Range
- $4.65 – $18.92
- 52-Week Range
- $4.65 – $1210.00
- Volume
- 2.82 million shs
- Average Volume
- 121K shs
- Market Cap
- $2.40 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.14
- Price / Sales
- —
Short Interest
- Short Interest
- 4.69%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-16,726,247
- Net Margin
- —
- Return on Equity
- -98.79%
- Debt-to-Equity
- —
About Genprex, Inc. Common Stock
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.